CRB-701

Corbus Pharmaceuticals Inc. · Phase 1 active Small molecule

At a glance

Generic name	CRB-701
Sponsor	Corbus Pharmaceuticals Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CRB-701 CI brief — competitive landscape report
CRB-701 updates RSS · CI watch RSS
Corbus Pharmaceuticals Inc. portfolio CI